Sure that has something to do with why the stock has been tanking this month. Hopefully some of the bad news is priced in. Although stock traded down to $6 AH, so maybe not. Sounds like it's a sector wide thing and a civil thing, so this could be much ado about nothing. Knee jerk reaction looks to be lower, so perhaps tomorrow could be a great buying opportunity?
Lots of stocks weak this month, especially microcaps like DAIO. So not sure anything is wrong (besides CFO's health concern). Might end up being a good buying opportunity.
DAIO has seen a pretty dramatic turnaround the last couple of quarters. Q3 earnings were .08/share vs. .02/share last year. Yet the stock price isn't much higher than it was a year ago. Strong balance sheet with $1.18/share in cash should give downside support.
I don't think upcoming Q4 results will be quite as good as Q3. But should show some big increases vs. the year ago Q4.
Yeah this is crazy! The panic selling is creating a terrific opportunity imo. CPSS earned .24/share in Q3. I'm guessing Q4 earnings will come in at .25+/share. The stock was trading in the $9's this time last year, and earnings are better now!
TSRI had a good report Friday after the close with fully-taxed earnings of .07/share vs. .02/share last year. Revenues up 20%. Check out the balance sheet. TSRI is sitting on $2.57/share in cash & securities!! They've also got a tiny share count with less than 2M shares O/S. So the potential to post some huge EPS in the coming quarters.
The number of consultants is increasing nicely. From 306 last year to 354 this year. Also a healthy sequential bump from 331. I think revenues will continue to climb. Bottom line a tougher call, and the current quarter is their seasonally worst quarter. But after that I wouldn't be surprised if TSRI posted a .10-.15 quarter later this year. This low floater would spike up to $6-$8. So a good one to accumulate near $4 imo.
I'd sell on the pop before people dig into the numbers. There was a hefty tax benefit in Q4. Looks like pre-tax income from cont. operations actually declined sequentially by quite a bit. From $4,225,273 in Q3 down to $2,844,520 in Q4. They earned a lightly taxed .11/share in Q3. I'm guessing Q4 earnings were only around .07/share if similarly taxed. I think people buying on the .20 number are going to regret it.
Yeah don't think it's tax loss selling. And no idea who would sell here. Very frustrating! Huge market rally with Dow up nearly 1,000 points in last 4 sessions...yet someone is unloading PESI in the $4.20's
Encouraging commentary from the CEO as well as the new Chairman:
Dr. Lou Centofanti, Chief Executive Officer, commented, "Larry has been a valuable resource to Perma-Fix since joining the board in 2006. His knowledge base on the environmental side of the business and his financial expertise make him ideally suited to take on the role of Chairman of the Board. Given the turnaround in our core business as well as the traction we are gaining within our medical isotope business, separating the roles of CEO and Chairman will provide us additional resources to evaluate and pursue various growth opportunities. At the same time, given his role as an independent board member, separation of the roles of Chairman and CEO further reinforces our commitment to good corporate governance."
Mr. Larry Shelton commented, "Through Dr. Centofanti's leadership, Perma-Fix has established itself as the market leader for nuclear waste treatment. The Company's sound fiscal practices and successful navigation of a difficult market environment, position Perma-Fix to resume solid growth and further expand our market presence. I am pleased to accept the role of Chairman of the Board and look forward to contributing my expertise and insight in ways that will enhance shareholder value."
ERS boosts working capital by $50M. CFO cites "current increasing business levels".
Sandra Kahn, Vice President and CFO, commented, "We are pleased to have secured this expanded working capital credit line from our world class bank group, which supports the current increasing business levels and provides us with additional liquidity for potential volume opportunities."
Some more insider buying. CEO bought another 1400 shares yesterday at $4.40. CFO bought 500 shares today at $4.36. A little good news here on a brutal day for the markets.
Haha a $50M contract with a Tier 1 company is no big deal?? You're quite the Debbie Downer! So are you short or what? Sevcon can do nothing right in your eyes. I feel like SEV could announce they're being acquired for $20/share...and you'd say yeah but it's by a company that does business in China.
That's almost 2X the current market cap! Next few years look very bright for this company. Just imagine what kind of numbers they'll put up when they have several contracts like this. SEV should fly on this news. I'm guessing we could back over $10 very soon, if not tomorrow!
Check the Form 4 filing just out. CEO bought 200,000 shares today at $2.17! How's that for a vote of confidence!! Stock didn't even trade that much volume today. So guessing it was an arranged purchase with Ellbar?
On strong volume too! Looks like the word is starting to get out about this company. It's not often you find a stock with excellent fundamentals (dramatic improvements in bottom line and over $2/share in cash on the books), buying by insiders (including the CEO), and involved in several hot areas (Big Data and Internet of Things). Who knows how high this one will fly when the momentum players find it. $5, $6, $7, $8. I think 2015 is going to be great year for BSQR.
Yeah great sign! Same director bought 5,000 shares in August at $3.75. Now he bought double that amount at $4.15. I think the writing is on the wall that the stock will be over $5 within a few months.
Wow lots of job postings the last couple months. Great to see! So we have a company that posted a strong Q3, has bullish Q4 guidance, has an awesome balance sheet with over $2/share in cash, a CEO that was buying stock last week at this price, along with the potential to become a Big Data play. Yes please!
ERS earned an adjusted .17/share in Q3 vs. only .04/share last year. Q3 revenues up 26%. Highest operating income in 4 years. Upbeat outlook. Seeing 'robust' demand in U.S. Should have a strong Q4 comp coming up. In this hot market where it's tough to find bargains, ERS sure looks undervalued. Should be trading at $6-$8 imo.